|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02587 HEALTHYWAY INC
Nominal 
() Profitability Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| ROAA (%) | -100.620% | -154.905% | -120.359% |
| ROAE (%) | N/A | N/A | 13.040% |
| Return on Capital Employed (%) | N/A | N/A | N/A |
Margin Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Gross Profit Margin (%) | 32.001% | 43.193% | 40.220% |
| EBITDA Margin (%) | -24.007% | -44.735% | -34.235% |
| Pre-tax Profit Margin (%) | -25.790% | -45.268% | -35.261% |
| Net Profit Margin (%) | -24.917% | -45.360% | -36.453% |
Liquidity Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Current Ratio (X) | 0.164 X | 0.101 X | 0.088 X |
| Quick Ratio (X) | 0.158 X | 0.098 X | 0.088 X |
Leverage Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Total Liabilities / Total Assets(%) | 499.347% | 810.978% | 1018.047% |
| Total Debt / Total Assets (%) | 23.352% | 26.643% | 11.691% |
| Net Debt / Total Assets (%) | -17.425% | -7.761% | -22.009% |
| Total Debt / Shareholders' Funds (%) | N/A | N/A | N/A |
| Long Term Debt / Shareholders' Funds (%) | N/A | N/A | N/A |
| Net Debt / Shareholders' Funds (%) | N/A | N/A | N/A |
| Net Cash / (Debt) ($) | 72.087M | 15.727M | 28.750M |
| Net Cash / (Debt) per share ($) | -- | -- | -- |
| Total Debt / Capital Employed (%) | N/A | N/A | N/A |
| Interest Coverage Ratio (X) | N/A | N/A | N/A |
Efficiency Analysis
| 2023/12 | 2022/12 | 2021/12 | |
| Inventory Turnover (Day) | 4.213 Day | 3.400 Day | 0.367 Day |
| Receivables Turnover (Day) | 22.099 Day | 24.384 Day | 32.942 Day |
| Payables Turnover (Day) | 16.922 Day | 13.429 Day | 10.834 Day |
| Remarks: | Real time quote last updated: 19/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (¥) | RMB -55,818,000 |
| %Change | -45.147% |
| EPS / (LPS) | RMB -- |
| NBV Per Share (¥) | RMB -- |